Skip to main content
Premium Trial:

Request an Annual Quote

Cellular Genomics Raises $34.9M in Series C Financing

NEW YORK, June 14 (GenomeWeb News) - Cellular Genomics has raised $34.9 million in a Series C private equity financing round, the Branford, Conn.-based company said today.

 

Cellular Genomics plans to use the funding to advance its drug development programs into the clinic. The company applies its chemical genetics platform both for in-house drug discovery and in collaborations with pharmaceutical and biotechnology companies, including Affymetrix, Eli Lilly, and Pfizer.

 

Previous investors Coastview Capital and Connecticut Innovations were joined by new investors CDP Capital, RiverVest Venture Partners, and Toucan Capital in this round.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.